NewsEvents

Your Yourlocation: Home > Clinical observation of salmeterol and fluticasone combined with tiotropium bromide(136310-93-5) in the treatment of moderate to severe chronic obstructive pulmonary disease

To investigate the clinical efficacy of salmeterol and fluticasone combined with cetropium bromide in the treatment of severe chronic obstructive pulmonary disease (COPD). Studies have shown that salmeterol fluticasone combined with tiotropium bromide(136310-93-5) in the treatment of severe COPD patients with significant clinical efficacy can improve lung function in patients. The article published on 2016 09 "Chinese community physicians".

Sixty patients with severe COPD were divided into two groups. Salmeterol and fluticasone combined with cetomide in treatment group were treated with salmeterol and fluticasone in the control group. The clinical efficacy was compared between the two groups.

After treatment, the differences of FVC, FEV1, FEV1 / FVC between the two groups were statistically significant (P <0.05). After treatment, SaO2, PaCO2, PaO2, the difference was statistically significant (P <0.05).

Address:211#Zhengfeng Building,Huanbaokejiyuan, Gaoxinkaifaqu, Jinan,250100,China TEL:086-531-82375818 Tiotropium Bromide
© Copyright(C)2014 JINAN DEXINJIA BIO & TECH CO., LTD All Rights Reserved